Target intelligence / Profile preview

Iron transport and binding protein

Molecular classification
Transporter, Receptor, Storage protein, Metal-binding protein
01

Overview

Iron transport and binding proteins constitute a diverse group of molecules essential for maintaining systemic and cellular iron homeostasis. This group includes proteins such as transferrin, which transports iron in the plasma; the transferrin receptor, which facilitates cellular iron uptake; ferritin, the primary intracellular iron storage protein; and ferroportin, the sole known cellular iron exporter [StatPearls: Iron Metabolism]. These proteins are critical because free iron is highly reactive and can catalyze the formation of damaging reactive oxygen species via the Fenton reaction [PubMed: PMC4129104]. Consequently, these proteins ensure that iron is safely sequestered and delivered to essential processes like hemoglobin synthesis and DNA replication [UniProt: P02787]. Dysregulation of these proteins is central to various pathologies, including iron-deficiency anemia, hereditary hemochromatosis, and certain neurodegenerative diseases [NIH: Iron Fact Sheet]. Pharmacological intervention often involves iron supplementation to treat deficiency, chelation therapy to remove excess iron in overload states, or emerging therapies targeting the hepcidin-ferroportin axis [PubMed: PMC3967028].

Other names
Iron metabolism proteinsIron-binding proteinsSiderophilins
02

Mechanism of action

Iron chelation (binding and removing excess iron), iron supplementation (replenishing systemic iron stores), hepcidin agonism (inducing ferroportin degradation), and ferroportin inhibition (blocking iron export).

03

Biological functions

Iron homeostasisIron transportIron storageErythropoiesisRedox regulation
04

Disease associations

AnemiaHemochromatosisIron overloadNeurodegenerative diseaseCancerInfection
05

Safety considerations

Oxidative stress from free ironGastrointestinal irritationHypersensitivity reactions to intravenous ironAgranulocytosis (associated with deferiprone)Renal and hepatic toxicity (associated with certain chelators)
06

Interacting drugs

Deferoxamine

6 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Soluble transferrin receptor (sTfR)HepcidinHemoglobin

Beyond the preview

Go deeper on Iron transport and binding protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron transport and binding protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call